AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionW Advisors, Llc
Latest Disclosed Ownership2,546 shares
Latest Disclosed Value $ 553,864
W Advisors, Llc reports 4.86% increase in ownership of 4AB / AbbVie Inc.

On April 29, 2026 - W Advisors, Llc filed a 13F-HR form disclosing ownership of 2,546 shares of AbbVie Inc. (BG:4AB) valued at $553,864 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,428 shares of AbbVie Inc.. This represents a change in shares of 4.86% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F ABBVIE COM 00287Y109 2,546 118 4.86 554 -0.18 0.1922
2026-02-13 2025-12-31 13F ABBVIE COM 00287Y109 2,428 8 0.33 555 -1.07 0.2790
2025-11-14 2025-09-30 13F ABBVIE COM 00287Y109 2,420 10 0.41 560 25.28 0.2951
2025-08-07 2025-06-30 13F ABBVIE COM 00287Y109 2,410 -14 -0.58 447 -11.83 0.2566
2025-05-13 2025-03-31 13F ABBVIE COM 00287Y109 2,424 81 3.46 508 21.88 0.3179
2025-01-22 2024-12-31 13F ABBVIE COM 00287Y109 2,343 -14 -0.59 416 -10.54 0.2575
2024-10-28 2024-09-30 13F ABBVIE COM 00287Y109 2,357 43 1.86 465 17.42 0.2866
2024-08-06 2024-06-30 13F ABBVIE COM 00287Y109 2,314 23 1.00 397 -5.04 0.2603
2024-04-25 2024-03-31 13F ABBVIE COM 00287Y109 2,291 18 0.79 417 18.47 0.2860
2024-02-06 2023-12-31 13F ABBVIE COM 00287Y109 2,273 51 2.30 352 6.34 0.2610
2023-11-13 2023-09-30 13F ABBVIE COM 00287Y109 2,222 27 1.23 331 12.20 0.2722
2023-08-04 2023-06-30 13F ABBVIE COM 00287Y109 2,195 1 0.05 296 -15.47 0.2317
2023-08-07 2023-03-31 13F ABBVIE COM 00287Y109 2,194 -52 -2.32 350 -3.86 0.2888
2023-02-07 2022-12-31 13F ABBVIE COM 00287Y109 2,246 55 2.51 363 23.47 0.3025
2022-10-24 2022-09-30 13F ABBVIE COM 00287Y109 2,191 -3 -0.14 294 -12.50 0.2736
2022-08-26 2022-06-30 13F ABBVIE COM 00287Y109 2,194 13 0.60 336 -4.82 0.2906
2022-08-26 2022-03-31 13F ABBVIE COM 00287Y109 2,181 194 9.76 353 31.23 0.2669
2022-08-15 2021-12-31 13F ABBVIE COM 00287Y109 1,987 1,987 269 0.2006
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.